ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for Mestinon®/- retard:MEDA Pharmaceuticals Switzerland GmbH
Complete information for professionalsDDDPrint 
Composition.Galenic FormIndication.UsageContra IndicationWarning restrictions.Interactions.Pregnancy
Driving abilityUnwanted effectsOverdoseEffectsPharm.kinetikPreclinicalOther adviceSwissmedic-Nr.
PackagesRegistration ownerLast update of information 

Galenische Form und Wirkstoffmenge pro Einheit

1 Tablette enthält 10 mg Pyridostigminbromid.
1 Dragée enthält 60 mg Pyridostigminbromid.
1 Retardtablette enthält 180 mg Pyridostigminbromid.

2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home